Entities / Company
Inspire Medical Systems (United States).
company in Maple Grove, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 30
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Trump pledged to unleash American oil and gas, while Warren Buffett discussed how share prices do not always rationally reflect value, impacting Inspire Medical Systems.Some support2 reports
-
Financial institutions UBS and Mizuho inquired about Inspire Medical Systems' inventory levels and CPT codes.Speculative1 report
-
Vertex Pharmaceuticals and Inspire Medical Systems both reported positive Earnings Stock Purchase Plan (ESP) figures.Some support1 report
-
Inspire Medical Systems reported that its revenue forecast growth exceeded the industry average.Some support2 reports
-
Share buyback program boosted investor confidence for Inspire Medical Systems, coinciding with a broader market rally due to favorable inflation data.Some support4 reports1 development inside
-
Inspire Medical Systems faced operational issues, as described by Tim Herbert on August 13, 2025.Some support1 report
-
Herbert attributed operational challenges, including rollout and billing delays, to Inspire Medical Systems.Some support2 reports
-
Nyxoah is entering the U.S. market with its GLP-1 drugs, adding to the competitive landscape of weight loss pharmaceuticals.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Herbert Structural
Herbert serves as the CEO of Inspire Medical Systems.
History
Events by the month they beganJune 2026
8 events- Trump pledged to unleash American oil and gas, while Warren Buffett discussed how share prices do not always rationally reflect value, impacting Inspire Medical Systems.
- Financial institutions UBS and Mizuho inquired about Inspire Medical Systems' inventory levels and CPT codes.
- Vertex Pharmaceuticals and Inspire Medical Systems both reported positive Earnings Stock Purchase Plan (ESP) figures.
- Inspire Medical Systems reported that its revenue forecast growth exceeded the industry average.
- Share buyback program boosted investor confidence for Inspire Medical Systems, coinciding with a broader market rally due to favorable inflation data.
- Inspire Medical Systems faced operational issues, as described by Tim Herbert on August 13, 2025.
- Herbert attributed operational challenges, including rollout and billing delays, to Inspire Medical Systems.
- Nyxoah is entering the U.S. market with its GLP-1 drugs, adding to the competitive landscape of weight loss pharmaceuticals.